revised international Chapel Hill consensus conference nomenclature of vasculitides, Arthritis Rheum, vol.65, pp.1-11, 2012. ,
DOI : 10.1002/art.37715
The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis, J Exp Med, vol.126, pp.989-1004, 1967. ,
Characterization of anti-GBM antibodies involved in Goodpasture's syndrome, Kidney Int, vol.46, pp.823-829, 1994. ,
Characterization of a single conformational epitope as a target of pathogenic autoantibodies, J Biol Chem, vol.274, pp.25862-25870, 1999. ,
Alport's syndrome, Goodpasture's syndrome and type IV collagen, N Engl J Med, vol.348, pp.2543-2556, 2003. ,
Identification of the alpha-3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome, J Am Soc Nephrol, vol.6, pp.1178-1185, 1995. ,
Isolation of the specific glomerular basement membrane antigen involved in Goodpasture syndrome, Proc Natl Acad Sci, vol.81, pp.1544-1548, 1984. ,
Clustering of Anti-GBM Disease. Clues to an Environmental Trigger?, Clin J Am Soc Nephrol, vol.11, issue.8, pp.1324-1326, 2016. ,
Spatial and temporal clustering of anti-glomerular basement membrane disease, Clin J Am Soc Nephrol, vol.11, pp.1392-1399, 2016. ,
Fever and prodromal infections in anti-glomerular basement membrane disease, Nephrology, 2017. ,
Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane, Lancet, vol.2, pp.1390-1393, 1983. ,
The association between hydrocarbure exposure and anti-GBM antibody-mediated disease, Am J Ind Med, vol.21, pp.141-153, 1992. ,
Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes, Kidney Int, vol.51, pp.222-229, 1997. ,
The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN, J Am Soc Nephrol, vol.24, pp.419-431, 2013. ,
The association of HLA-DQB1,-DQA1 and -DPB alleles with anti-glomerular basement membrane disease in Chinese patients, BMC Nephrol, vol.12, p.21, 2011. ,
Properties of HLA class II molecules divergently associated with Goodpasture's disease, Int Immunology, issue.12, pp.1135-1143, 2000. ,
Goodpasture's disease, Lancet, vol.358, pp.917-920, 2001. ,
Antiglomerular basement membrane disease, Kidney Int, vol.64, pp.1535-1550, 2003. ,
The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3 (IV) NC1 is associated with disease severity ,
, Hum Immunol, vol.70, pp.425-429, 2009.
Antigen restriction and IgG subclasses among anti-GBM autoantibodies, Nephrol Dial Transplant, vol.5, pp.991-996, 1990. ,
DOI : 10.1093/ndt/5.12.991
,
, Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease, J Am Soc Nephrol, vol.22, 1946.
Anti-glomerular basement membrane glomerulonephritis: A morphologic study of 80 cases, Am J Clin Pathol, vol.125, pp.445-450, 2006. ,
Rapidly progressive crescentic glomerulonephritis, Kidney Int, vol.63, pp.1164-1177, 2003. ,
ANCA-associated vasculitis and anti-GBM disease: the experience in China, Nephrol Dial Transplant, vol.25, pp.2062-2065, 2010. ,
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients, Kidney Int, vol.92, pp.693-702, 2017. ,
Prognostic implication of anti-neutrophil cytoplasmic antoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease, Clin Nephrol, vol.36, pp.107-113, 1991. ,
Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis, Kidney Int, vol.37, pp.965-970, 1990. ,
DOI : 10.1038/ki.1990.72
URL : https://doi.org/10.1038/ki.1990.72
Clinical features and outcome of patients with both ANCA and anti-GBM antibodies, Kidney Int, vol.66, pp.1535-1540, 2004. ,
DOI : 10.1111/j.1523-1755.2004.00917.x
URL : https://doi.org/10.1111/j.1523-1755.2004.00917.x
Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane, Ther Apher Dial, vol.13, pp.278-281, 2009. ,
, Kidney Disease Improving Global Outcomes (KDIGO) Glomerulonephritis Wok Group: KDIGO clinical practice guideline for glomerulonephritis, Kidney Int, pp.139-274, 2012.
Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression, Ann Intern Med, vol.134, pp.1033-1042, 2001. ,
DOI : 10.7326/0003-4819-134-11-200106050-00009
Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption, Plos One, vol.9, p.103568, 2017. ,
Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis, BMC Nephrol, vol.15, p.128, 2014. ,
European Vasculitis Study Group): Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: A randomized trial, Ann Intern Med, vol.150, pp.670-680, 2009. ,
Rituximab in anti-GBM disease: a retrospective study of 8 patients, J Autoimmun, vol.60, pp.74-79, 2015. ,
Anti-glomerular basement membrane disease treated with mycophenolate mofetil, corticosteroids and plasmapheresis, Clin Nephrol, vol.80, pp.67-71, 2013. ,
DOI : 10.5414/cn107333
,
, Goodpasture's syndrome treated with mycophenolate mofetil, Nephrol Dial Transplant, vol.15, pp.920-922, 2000.
Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of two center cohort ,
, Nephro Dial Transplant, vol.30, pp.814-821, 2015.
Predicting outcome in patients with anti-GBM glomerulonephritis, Clin J Am Soc Nephrol, vol.13, pp.63-72, 2018. ,
The prognostic significance in Goodpasture's disease of specificity, titre and affinity of antiglomerular-basement-membrane antibodies ,
, Nephron Clin Pract, vol.94, pp.59-68, 2003.
Characteristics and outcomes of patients with Goodpasture's syndrome, South Med J, vol.95, pp.1411-1418, 2002. ,
Outcomes of patients with Goodpasture syndrome: A nationwide cohort-based study from French Society of Hemapheresis, J Autoimmun, vol.73, pp.24-29, 2016. ,
Levels of epitopespecific autoantibodies correlate with renal damage in anti-GBM disease, Nephrol dial Transplant, vol.24, pp.1838-1844, 2009. ,
Multiple reccurences of anti-GBM disease with variable antibody detection: can the laboratory be trusted?, Clin Kidney J, vol.9, pp.657-660, 2016. ,
Frequently relapsing anti-GBM disease with changing clinical phenotype and antibody characteristics over time, Clin Kidney J, vol.9, pp.661-664, 2016. ,
DOI : 10.1093/ckj/sfw048
URL : https://academic.oup.com/ckj/article-pdf/9/5/661/8038015/sfw048.pdf
Recurrent Goodpasture's disease, Am J Kidney Dis, vol.27, pp.573-578, 1996. ,
,
, Am J Transplant, vol.6, pp.2535-2542, 2006.
Anti-GBM disease is an uncommon cause of end-stage renal disease, Kidney Int, vol.83, pp.503-510, 2013. ,
Histopathologic classification of ANCA-associated glomerulonephritis, J Am Soc Nephrol, vol.10, pp.1628-1664, 2010. ,
Anti-Glomerular Basement Membrane Disease Outcomes of Different Therapeutic Regimens in a Large SingleCenter Chinese Cohort Study, Medicine, vol.90, pp.303-311, 2011. ,
Mortality in ANCAassociated vasculitis: a meta-analysis of observational studies, Ann Rheum Dis, 2017. ,
Outcome and treatment of Elderly patients with ANCA associated vasculitis, Clin J Am Soc Nephrol, vol.10, pp.1128-1135, 2015. ,
Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis, Ann Rheum Dis, vol.69, issue.6, pp.1036-1079, 2010. ,
Clinical outcomes of ANCA-associated vasculitis in elderly patients, Int Urol Nephrol, vol.46, pp.1595-160, 2014. ,
, , p.12
, , p.22
, , p.22
, Données exprimées en n (%), médiane [Interquartiles Range
, CV, cardiovasculaires ; Anti-MBG, anticorps anti-membrane basale glomérulaire
, ANCA, anticorps anti cytoplasme des polynucléaires neutrophiles
Protéinase 3 ; SCr, serum creatinine, p.3 ,